KBC Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56M Buy
646,039
+215,531
+50% +$20.6M 0.14% 143
2025
Q4
$41.4M Buy
430,508
+21,384
+5% +$2.08M 0.09% 177
2025
Q3
$39M Buy
409,124
+14,098
+4% +$1.3M 0.09% 186
2025
Q2
$34.4M Buy
395,026
+4,776
+1% +$405K 0.09% 202
2025
Q1
$35.1M Sell
390,250
-294,010
-43% -$26.3M 0.11% 193
2024
Q4
$54.7M Buy
684,260
+29,981
+5% +$2.6M 0.15% 134
2024
Q3
$58.9M Buy
654,279
+287,396
+78% +$24.2M 0.18% 112
2024
Q2
$28.9M Sell
366,883
-29,490
-7% -$2.42M 0.09% 197
2024
Q1
$34.5M Sell
396,373
-510,089
-56% -$43.5M 0.11% 184
2023
Q4
$74.7M Buy
906,462
+104,726
+13% +$7.98M 0.26% 85
2023
Q3
$62.8M Buy
801,736
+71,115
+10% +$5.95M 0.26% 88
2023
Q2
$64.4M Sell
730,621
-361,773
-33% -$31.1M 0.26% 79
2023
Q1
$88.1M Buy
1,092,394
+621,726
+132% +$50.7M 0.37% 59
2022
Q4
$36.6M Sell
470,668
-23,281
-5% -$1.89M 0.18% 128
2022
Q3
$39.9M Buy
493,949
+86,162
+21% +$7.74M 0.21% 111
2022
Q2
$36.6M Buy
407,787
+80,527
+25% +$8.16M 0.18% 133
2022
Q1
$36.3M Sell
327,260
-118,215
-27% -$12.5M 0.14% 171
2021
Q4
$46.1M Sell
445,475
-417,487
-48% -$48.3M 0.15% 160
2021
Q3
$108M Sell
862,962
-1,646,042
-66% -$213M 0.4% 59
2021
Q2
$311M Buy
2,509,004
+12,960
+0.5% +$1.63M 0.56% 35
2021
Q1
$295M Buy
2,496,044
+13,936
+0.6% +$1.63M 0.6% 36
2020
Q4
$1.58B Sell
2,482,108
-238,158
-9% -$26.2M 0.67% 23
2020
Q3
$283M Buy
2,720,266
+106,688
+4% +$10.7M 0.83% 19
2020
Q2
$240M Buy
2,613,578
+1,150,493
+79% +$110M 0.8% 25
2020
Q1
$132M Buy
1,463,085
+558,386
+62% +$59.4M 1.1% 11
2019
Q4
$103M Sell
904,699
-87,612
-9% -$9.61M 0.65% 26
2019
Q3
$108M Buy
992,311
+243,075
+32% +$25.4M 0.79% 21
2019
Q2
$73M Buy
749,236
+59,322
+9% +$5.42M 0.56% 29
2019
Q1
$62.8M Buy
689,914
+254,245
+58% +$22.8M 0.52% 35
2018
Q4
$39.6M Sell
435,669
-8,762
-2% -$819K 0.44% 52
2018
Q3
$43.7M Sell
444,431
-21,353
-5% -$1.97M 0.33% 72
2018
Q2
$39.9M Sell
465,784
-192,678
-29% -$16.1M 0.35% 65
2018
Q1
$52.8M Buy
658,462
+15,823
+2% +$1.31M 0.49% 40
2017
Q4
$51.9M Sell
642,639
-168,172
-21% -$13.5M 0.44% 48
2017
Q3
$63.1M Sell
810,811
-210,404
-21% -$17.5M 0.57% 30
2017
Q2
$90.6M Sell
1,021,215
-64,054
-6% -$5.4M 0.88% 15
2017
Q1
$87.4M Buy
1,085,269
+106,706
+11% +$8.34M 0.79% 16
2016
Q4
$69.7M Buy
978,563
+388,856
+66% +$30.5M 0.69% 19
2016
Q3
$51M Buy
589,707
+180,926
+44% +$15.8M 0.6% 26
2016
Q2
$35.5M Sell
408,781
-24,264
-6% -$1.96M 0.51% 36
2016
Q1
$32.5M Buy
433,045
+48,059
+12% +$3.62M 0.54% 31
2015
Q4
$29.6M Buy
384,986
+40,380
+12% +$3.04M 0.55% 32
2015
Q3
$23.1M Sell
344,606
-149,714
-30% -$11M 0.46% 44
2015
Q2
$36.6M Sell
494,320
-59,229
-11% -$4.53M 0.47% 41
2015
Q1
$43.2M Buy
553,549
+158,616
+40% +$12M 0.55% 32
2014
Q4
$28.5M Buy
394,933
+360,709
+1,054% +$25.1M 0.34% 67
2014
Q3
$2.12M Sell
34,224
-350,878
-91% -$22.3M 0.07% 332
2014
Q2
$24.6M Buy
385,102
+9,392
+2% +$571K 0.28% 72
2014
Q1
$23.1M Sell
375,710
-91,815
-20% -$5.35M 0.37% 55
2013
Q4
$26.8M Sell
467,525
-132,202
-22% -$7.5M 0.41% 53
2013
Q3
$31.9M Buy
599,727
+340,980
+132% +$18.3M 0.51% 37
2013
Q2
$13.3M Buy
+258,747
New +$12.8M 0.25% 100

Other funds holding MDT

KBC Group's MDT Position: Q1 2026 in Review

KBC Group increased its Medtronic (MDT) stake by 50% in Q1 2026, buying an estimated $20.6M and bringing the position to 646,039 shares worth $56M. The position accounts for 0.14% of the portfolio, ranked #143.

KBC Group first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.58B in Q4 2020. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • KBC Group held 646,039 shares of Medtronic worth $56M as of Q1 2026.
  • KBC Group bought 215,531 Medtronic shares in Q1 2026, an estimated $20.6M.
  • Medtronic made up 0.14% of KBC Group's portfolio in Q1 2026, its #143 holding.
  • KBC Group first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Medtronic position peaked at $1.58B in Q4 2020.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.